|
Listen to this text  |
The Monarch platform for robot-assisted urology procedures. | Source: Johnson & Johnson’s Ethicon
Ethicon, a Johnson & Johnson MedTech firm, in the present day introduced the primary robotic-assisted elimination of kidney stones utilizing the Monarch platform.
Auris Health, an Ethicon subsidiary, obtained FDA clearance for Monarch for endourological procedures in May 2022. The University of California, Irvine’s UCI Health used the Monarch platform for urology to finish the primary process.
According to a information launch, it’s the primary profitable robotically assisted, electromagnetic-guided percutaneous entry and mini-percutaneous nephrolithotomy process. Ethicon stated its examine entails a collaboration with co-investigator Dr. Mihir Desai from the University of Southern California.
Robotics Summit & Expo (May 10-11) returns to Boston
Martin Buehler, Global Head of Robotics R&D at Johnson & Johnson MedTech, can be keynoting the Robotics Summit on May 11, 2023, at 10 AM. Buehler’s speak, “The Future of Surgical Robotics”, will give an inside have a look at the end-to-end growth of its Monarch and Ottava robotics platforms, in addition to technique and innovation cadence throughout surgical robotics for MedTech.
“This clinical study is the first in the world to research and demonstrate the potential for improved navigation, access, clearance and control in mini-PCNL procedures using the Monarch platform for urology,” stated Dr. Jaime Landman, chair of the UCI School of Medicine Department of Urology and director of the UCI Health Kidney Stone & Kidney Disease Services. “In addition to potentially helping urologists achieve stone-free patients in a single procedure, this approach could help reduce the need for retreatment after kidney stone removal and decrease risks and complication rates.”
Ethicon’s scientific group led the primary case in its scientific examine. It goals to gather efficiency knowledge on robotic mini-PCNL procedures to optimize Monarch and inform coaching and training.
“The prevalence of kidney stones remains high, and many urologists seek a new treatment option that reduces overall retreatment and complication rates,” Desai stated. “In patients who require treatment through surgery, close to one in two will require retreatment within five years.”
About the Ethicon Monarch platform
Ethicon designed the Monarch robot-assisted surgical platform to allow urologists to succeed in and visualize areas throughout the kidney with precision and management. The system presents one platform for supporting each ureteroscopic and PCNL procedures.
The Monarch platform for urology permits for navigation by the kidney with a handheld controller. Robotic help offers surgeons a method to exactly preserve instrument positions and carry out a number of duties concurrently. It makes use of a novel electromagnetic concentrating on platform to provide urologists extra exact entry to the kidney.
According to Ethicon, Monarch gives 80% much less radiation publicity throughout percutaneous entry in comparison with commonplace fluoroscopic-guided entry methods. It additionally presents consistency with fewer needle sticks when acquiring entry, the corporate stated.
“After years of work, we are thrilled to be a part of this first clinical series which introduces a new treatment to improve outcomes for patients in need,” Landman stated.
Editor’s Note: This article first appeared on sister web site MassDevice.